AzTrials
AzTrials

Young Adult Behavioral ChangeNCT02379325

Text Message Stop Smoking Among Young Population

A study testing Lets Quit and pamphlets material in people with Young Adult Behavioral Change, run by Universiti Kebangsaan Malaysia Medical Centre.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Smoking cessation is a priority for preventing smoking-attributable disease and reducing its burden. Quitting smoking at any age confers substantial and immediate health benefits, including reduced risks of stroke, cardiovascular disease and smoking-related cancers, and quitting smoking by the age of 30 reduces the… Read more about this study

Who is it for?
Ages 20 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Young Adult Behavioral Change
What is being tested?
Lets Quit and pamphlets material
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Apr 2014to Jun 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Smokers aged 18 - 24 years old
  • Owned a mobile phone with text messaging capabilities
  • Intention to quit
  • No current use of nicotine replacement treatment or bupropion in the past month
  • Not in treatment for any substance abuse disorder within the past year

Who cannot join

  • Not a smoker
  • No desire to quit smoking-
  • Who unwillingly to participate in this study

About this study

Official title: 4-Weeks Intervention of Mobile Phone Text Messaging (Let's Quit!) on Smoking Cessation Among University Students: A Non Randomized Controlled Trial

Smoking cessation is a priority for preventing smoking-attributable disease and reducing its burden. Quitting smoking at any age confers substantial and immediate health benefits, including reduced risks of stroke, cardiovascular disease and smoking-related cancers, and quitting smoking by the age of 30 reduces the risk of dying from tobacco-related diseases by almost 90%. The World Bank suggests that if adult cigarette consumption were to decrease by half in the year 2020, approximately 180 million tobacco-attributable deaths could be avoided. Therefore, promotion of smoking cessation has been proposed as a primary focus of tobacco control efforts, especially in developing countries where smoking prevalence and cigarette consumption are both still relatively high

Read the detailed description

most risk factors are associated with more than one disease, and targeting those factors can reduce multiple causes of disease. Since smoking has 9% contributions on the leading global risk towards mortality in the world and this risk factor has resulted in multiple causes of disease for example, lung cancer, heart disease, stroke, chronic respiratory disease and other conditions therefore by quantifying the impact of this risk factors on diseases, may help to decrease the number of burden disease that is caused by smoking. University students age of 18 -24 are among the group of age that has the highest prevalence on smoking, thus it is necessary to targeting the high-risk people, who are most likely to benefit from the intervention. Population-based strategies seek to change the social norm by encouraging an increase in healthy behavior and a reduction in health risk. University students are in transition between the adolescence and early adulthood and developed unhealthy behaviors like cigarette smoking

Being tested
Lets Quit, pamphlets material

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lets QuitBehavioural

    Five tracks were created including "Not Ready", "Beginner", "Advance", "Relapse", and "Distraction". The "Distraction" track was combined with all of the other remaining 4 tracks. It was aimed as a distraction (as the name indicated) method to lighten the participants mood. It consisted of general information such as sports, fashion, dining, movies, and travelling.

  • pamphlets materialBehavioural

    Given pamphlets material on smoking and complication

Study groups in NCT02379325
Study groupRoleWhat they receive
Lets QuitExperimentalGiven text message
Receives: Behavioral: Lets Quit; Behavioral: pamphlets material
Pamplets educationActive comparatorGiven pamplets on smoking and complication
Receives: Behavioral: Lets Quit; Behavioral: pamphlets material

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quit rates

    Measured: 2 months

  2. Time-line follow-back (TLFB)

    Measured: 2 months

  3. The Fagerstrom Test for Nicotine Dependence

    Measured: 2 months

  4. CO level

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2015 (estimated)
  2. Study startApr 2014
  3. Primary completionJun 2014
  4. Study completionJun 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02379325
Sponsor's protocol ID
Lets Quit
Status last verified
Feb 2015
First submitted
5 Feb 2015
Last updated
4 Mar 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Lets Quit and pamphlets material in people with Young Adult Behavioral Change, run by Universiti Kebangsaan Malaysia Medical Centre.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quit rates (time frame: 2 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in